156 related articles for article (PubMed ID: 12466030)
21. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.
Feder A; Parides MK; Murrough JW; Perez AM; Morgan JE; Saxena S; Kirkwood K; Aan Het Rot M; Lapidus KA; Wan LB; Iosifescu D; Charney DS
JAMA Psychiatry; 2014 Jun; 71(6):681-8. PubMed ID: 24740528
[TBL] [Abstract][Full Text] [Related]
23. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
[TBL] [Abstract][Full Text] [Related]
24. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.
Goff DC; Tsai G; Manoach DS; Coyle JT
Am J Psychiatry; 1995 Aug; 152(8):1213-5. PubMed ID: 7625475
[TBL] [Abstract][Full Text] [Related]
25. A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia.
Goff DC; Henderson DC; Evins AE; Amico E
Biol Psychiatry; 1999 Feb; 45(4):512-4. PubMed ID: 10071726
[TBL] [Abstract][Full Text] [Related]
26. D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.
Levinson CA; Rodebaugh TL; Fewell L; Kass AE; Riley EN; Stark L; McCallum K; Lenze EJ
J Clin Psychiatry; 2015 Jun; 76(6):e787-93. PubMed ID: 26132687
[TBL] [Abstract][Full Text] [Related]
27. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder.
de Kleine RA; Hendriks GJ; Smits JA; Broekman TG; van Minnen A
J Psychiatr Res; 2014 Jan; 48(1):40-6. PubMed ID: 24183818
[TBL] [Abstract][Full Text] [Related]
28. Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia.
Heresco-Levy U; Javitt DC; Ermilov M; Silipo G; Shimoni J
Int J Neuropsychopharmacol; 1998 Dec; 1(2):131-135. PubMed ID: 11281957
[TBL] [Abstract][Full Text] [Related]
29. Low-dose cortisol for symptoms of posttraumatic stress disorder.
Aerni A; Traber R; Hock C; Roozendaal B; Schelling G; Papassotiropoulos A; Nitsch RM; Schnyder U; de Quervain DJ
Am J Psychiatry; 2004 Aug; 161(8):1488-90. PubMed ID: 15285979
[TBL] [Abstract][Full Text] [Related]
30. A randomized placebo-controlled pilot study of the efficacy and safety of D-cycloserine in people with chronic back pain.
Schnitzer TJ; Torbey S; Herrmann K; Kaushal G; Yeasted R; Vania Apkarian A
Mol Pain; 2016; 12():. PubMed ID: 27852965
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis.
Heresco-Levy U; Javitt DC
Schizophr Res; 2004 Feb; 66(2-3):89-96. PubMed ID: 15061240
[TBL] [Abstract][Full Text] [Related]
32. Effects of D-cycloserine on negative symptoms in schizophrenia.
Duncan EJ; Szilagyi S; Schwartz MP; Bugarski-Kirola D; Kunzova A; Negi S; Stephanides M; Efferen TR; Angrist B; Peselow E; Corwin J; Gonzenbach S; Rotrosen JP
Schizophr Res; 2004 Dec; 71(2-3):239-48. PubMed ID: 15474895
[TBL] [Abstract][Full Text] [Related]
33. Effects of 35% carbon dioxide (CO
Kellner M; Muhtz C; Nowack S; Leichsenring I; Wiedemann K; Yassouridis A
J Psychiatr Res; 2018 Jan; 96():260-264. PubMed ID: 29128558
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
Otto MW; Tolin DF; Simon NM; Pearlson GD; Basden S; Meunier SA; Hofmann SG; Eisenmenger K; Krystal JH; Pollack MH
Biol Psychiatry; 2010 Feb; 67(4):365-70. PubMed ID: 19811776
[TBL] [Abstract][Full Text] [Related]
35. IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans.
D'Souza DC; Gil R; Cassello K; Morrissey K; Abi-Saab D; White J; Sturwold R; Bennett A; Karper LP; Zuzarte E; Charney DS; Krystal JH
Biol Psychiatry; 2000 Mar; 47(5):450-62. PubMed ID: 10704956
[TBL] [Abstract][Full Text] [Related]
36. Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial.
Mataix-Cols D; Turner C; Monzani B; Isomura K; Murphy C; Krebs G; Heyman I
Br J Psychiatry; 2014 Jan; 204(1):77-8. PubMed ID: 24262813
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study.
Isserles M; Shalev AY; Roth Y; Peri T; Kutz I; Zlotnick E; Zangen A
Brain Stimul; 2013 May; 6(3):377-83. PubMed ID: 22921765
[TBL] [Abstract][Full Text] [Related]
38. D-Cycloserine Facilitates Reversal in an Animal Model of Post-traumatic Stress Disorder.
George SA; Rodriguez-Santiago M; Riley J; Abelson JL; Floresco SB; Liberzon I
Behav Brain Res; 2018 Jul; 347():332-338. PubMed ID: 29580893
[TBL] [Abstract][Full Text] [Related]
39. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
40. D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia.
Gottlieb JD; Cather C; Shanahan M; Creedon T; Macklin EA; Goff DC
Schizophr Res; 2011 Sep; 131(1-3):69-74. PubMed ID: 21723096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
